In silico selection of an aptamer to estrogen receptor alpha using computational docking employing estrogen response elements as aptamer-alike molecules

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Ahirwar, Rajesh ^a,b   Nahar, Smita ^a,b   Aggarwal, Shikha ^b   Ramachandran, Srinivasan ^a,b   Maiti, Souvik ^a,b   Nahar, Pradip ^a,b  

^a ACADEMY OF SCIENTIFIC AND INNOVATIVE RESEARCH ACSIR   (India)

^b NATIONAL CHEMICAL LABORATORY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

APTAMER; DNA BINDING PROTEIN; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR ALPHA, HUMAN; PROTEIN BINDING;

ANTAGONISTS AND INHIBITORS; BIOLOGY; BREAST NEOPLASMS; CHEMISTRY; DNA RESPONSIVE ELEMENT; FEMALE; GENETICS; HUMAN; INVERTED REPEAT; METABOLISM; MOLECULAR DOCKING; NUCLEOTIDE SEQUENCE; SYSTEMATIC EVOLUTION OF LIGANDS BY EXPONENTIAL ENRICHMENT APTAMER TECHNIQUE;

APTAMERS, NUCLEOTIDE; BASE SEQUENCE; BREAST NEOPLASMS; COMPUTATIONAL BIOLOGY; DNA-BINDING PROTEINS; ESTROGEN RECEPTOR ALPHA; ESTROGENS; FEMALE; HUMANS; INVERTED REPEAT SEQUENCES; MOLECULAR DOCKING SIMULATION; PROTEIN BINDING; RESPONSE ELEMENTS; SELEX APTAMER TECHNIQUE;

EID: 84959362862     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep21285     Document Type: Article

References (56)

1. Weigel, M. T., Dowsett, M. Current and emerging biomarkers in breast cancer: prognosis and prediction. Endocr Relat Cancer 17, R245-262 (2010)
2. Ali, S., Coombes, R. C. Estrogen receptor alpha in human breast cancer: Occurrence and significance. J Mammary Gland Biol Neoplasia 5, 271-281 (2000).
3. Lippman, M. E., Allegra, J. C. Quantitative estrogen receptor analysis: The response to endocrine and cytotoxic chemotherapy in human breast cancer and the disease-free interval. Cancer 46, 2829-2834 (1980).
4. Fisher, B. et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 90, 1371-1388 (1998).
5. Sawaki, M. et al. High-dose toremifene as first-line treatment of metastatic breast cancer resistant to adjuvant aromatase inhibitor: A multicenter phase II study. Oncol Lett 3, 61-65 (2012).
6. Wakeling, A. E., Dukes, M., Bowler, J. A potent specific pure antiestrogen with clinical potential. Cancer Res 51, 3867-3873 (1991).
7. GomezFernandez, C., Mejias, A., Walker, G., Nadji, M. Immunohistochemical expression of estrogen receptor in adenocarcinomas of the lung: the antibody factor. Appl Immunohistochem Mol Morphol 18, 137-141 (2010).
8. Kobayashi, S. et al. Comparison of five different antibodies in the immunohistochemical assay of estrogen receptor alpha in human breast cancer. Breast Cancer 7, 136-141 (2000).
9. Marx, V. Calling the next generation of affinity reagents. Nat Methods 10, 829-833 (2013).
10. Ellington, A. D., Szostak, J. W. In vitro selection of RNA molecules that bind specific ligands. Nature 346, 818-822 (1990).
11. Tuerk, C., Gold, L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249, 505-510 (1990).
12. Ni, X., Castanares, M., Mukherjee, A., Lupold, S. E. Nucleic acid aptamers, clinical applications and promising new horizons. Curr Med Chem 18, 4206-4214 (2011).
13. Osborne, S. E., Ellington, A. D. Nucleic acid selection and the challenge of combinatorial chemistry. Chem Rev 97, 349-370 (1997).
14. Xu, D., Chatakonda, V. K., Kourtidis, A., Conklin, D. S., Shi, H. In search of novel drug target sites on estrogen receptors using RNA aptamers. Nucleic acid Ther 24, 226-238 (2014).
15. He, X. et al. Using a sequence of estrogen response elements as a DNA aptamer for estrogen receptors in vitro. Nucleic acid Ther 00, 1-10 (2015).
16. Chushak, Y., Stone, M. O. In silico selection of RNA aptamers. Nucleic Acids Res 37, e87 (2009).
17. Collett, J. R. et al. Functional RNA microarrays for high-throughput screening of antiprotein aptamers. Anal Biochem 338, 113-123 (2005).
18. Driscoll, M. D. et al. Sequence requirements for estrogen receptor binding to estrogen response elements. J Biol Chem 273, 29321-29330 (1998).
19. Gruber, C. J., Gruber, D. M., Gruber, I. M., Wieser, F., Huber, J. C. Anatomy of the estrogen response element. Trends Endocrinol Metab 15, 73-78 (2004).
20. Trott, O., Olson, A. J. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function: efficient optimization and multithreading. J Comput Chem 31, 455-461 (2010).
21. Vries, S. J., de Dijk, M., van Bonvin, A. M. J. J. The HADDOCK web server for data-driven biomolecular docking. Nat Protoc 5, 883-897 (2010).
22. Schneidman-Duhovny, D., Inbar, Y., Nussinov, R., Wolfson, H. J. PatchDock and SymmDock: servers for rigid and symmetric docking. Nucleic Acids Res 33, W363-367 (2005).
23. Sanchez, R., Nguyen, D., Rocha, W., White, J. H., Mader, S. Diversity in the mechanisms of gene regulation by estrogen receptors. Bioessays 24, 244-254 (2002).
24. Parisien, M., Major, F. The MC-Fold and MC-Sym pipeline infers RNA structure from sequence data. Nature 452, 51-55 (2008).
25. Long, S. B., Long, M. B., White, R. R., Sullenger, B. A. Crystal structure of an RNA aptamer bound to thrombin. RNA 14, 2504-2512 (2008).
26. Jellinek, D., Green, L. S., Bell, C., Janjic, N. Inhibition of Receptor Binding by High-Affinity RNA Ligands to Vascular Endothelial Growth Factor. Biochemistry 33, 10450-10456 (1994).
27. Olson, C. L. In Essentials of Statistics: Making Sense of Data (Boston: Allyn and Bacon, Inc., 1987).
28. Hermann T., Patel D. J. Adaptive recognition by nucleic acid aptamers. Science 287, 820-825 (2000).
29. Ahirwar, R., Nahar, P. Screening and Identification of a DNA Aptamer to Concanavalin A and Its Application in Food Analysis. J Agri Food Chem 63, 4104-4111 (2015).
30. Cho, M. et al. Quantitative selection of DNA aptamers through microfluidic selection and high-throughput sequencing. Proc Natl Acad Sci USA 107, 15373-15378 (2010).
31. Hu, W. P., Kumar, J. V., Huang, C. J., Chen, W. Y. Computational selection of RNA aptamer against angiopoietin-2 and experimental evaluation. BioMed Res Int 2015, 65871, doi: 10.1155/2015/658712 (2015).
32. Caroli, J., Taccioli, C., De La Fuente, A., Serafini, P., Bicciato, S. APTANI: a computational tool to select aptamers through sequence-structure motif analysis of HT-SELEX data. Bioinformatics, doi: 10.1093/bioinformatics/btv545 (2015).
33. Luo, X. et al. Computational approaches toward the design of pools for the in vitro selection of complex aptamers. RNA 16, 2252-2262 (2010).
34. Silverman, S. K. Deoxyribozymes: DNA catalysts for bioorganic chemistry. Org Biomol Chem 2, 2701-2706 (2004).
35. Germer, K., Leonard, M., Zhang, X. RNA aptamers and their therapeutic and diagnostic applications. Int J Biochem Mol Biol 4, 27-40 (2013).
36. Schwabe, J. W., Chapman, L., Finch, J. T., Rhodes, D. The crystal structure of the estrogen receptor DNA-binding domain bound to DNA: how receptors discriminate between their response elements. Cell 75, 567-576 (1993).
37. Wang, L., Brown, S. J. BindN: a web-based tool for efficient prediction of DNA and RNA binding sites in amino acid sequences. Nucleic Acids Res 34, W245-W248 (2006).
38. Mashiach, E., Schneidman-Duhovny, D., Andrusier, N., Nussinov, R., Wolfson, H. J. FireDock: a web server for fast interaction refinement in molecular docking. Nucleic Acids Res 36, W229-W232 (2008).
39. Soto, A. M., Kankia, B. I., Dande, P., Gold, B., Marky, L. A. Thermodynamic and hydration effects for the incorporation of a cationic 3-aminopropyl chain into DNA. Nucleic Acids Res 30, 3171-3180 (2002).
40. Kyo, S. et al. Estrogen activates telomerase. Cancer Res 59, 5917-5921 (1999).
41. Berry, M., Nunez, A.-M., Chambon, P. Estrogen-responsive element of the human pS2 gene is an imperfectly palindromic sequence. Proc Natl Acad Sci USA 86, 1218-1222 (1989).
42. Choi, I., Gudas, L. J., Katzenellenbogen, B. S. Regulation of keratin 19 gene expression by estrogen in human breast cancer cells and identification of the estrogen responsive gene region. Mol Cell Endocrinol 164, 225-237 (2000).
43. Richard, S., Zingg, H. H. The human oxytocin gene promoter is regulated by estrogens. J Biol Chem 265, 6098-6103 (1990).
44. Citarella, F. et al. Estrogen induction and contact phase activation of human factor XII. Steroids 61, 270-276 (1996).
45. Fan, D., Wagner, B. L., McDonnell, D. P. Identification of the sequences within the human complement 3 promoter required for estrogen responsiveness provides insight into the mechanism of tamoxifen mixed agonist activity. Mol Endocrinol 10, 1605-1616 (1996).
46. Zhang, Z., Teng, C. T. Estrogen receptor-related receptor a1 interacts with coactivator and constitutively activates the estrogen response elements of the human lactoferrin gene. J Biol Chem 275, 20837-20846 (2000).
47. Zhao, Y. Y., Zhou, J., Narayanan, C. S., Cui, Y., Kumar, A. Role of C/A polymorphism at-20 on the expression of human angiotensinogen gene. Hypertension 33, 108-115 (1999).
48. El-Ashry, D., Chrysogelos, S. A., Lippman, M. E., Kern, F. G. Estrogen induction of TGF-? is mediated by an estrogen response element composed of two imperfect palindromes. J Steroid Biochem Mol Biol 59, 261-269 (1996).
49. Vyhlidal, C., Samudio, I., Kladde, M. P., Safe, S. Transcriptional activation of transforming growth factor ? by estradiol: requirement for both a GC-rich site and an estrogen response element half-site. J Mol Endocrinol 24, 329-338 (2000).
50. Mueller, M. D. et al. Regulation of vascular endothelial growth factor (VEGF) gene transcription by estrogen receptors ? and ? . Proc Natl Acad Sci USA 97, 10972-10977 (2000).
51. Seth, P., et al. Cellular and molecular targets of estrogen in normal human breast tissue. Cancer Res 62, 4540-4544 (2002).
52. Wang, F., Porter, W., Xing, W., Archer, T. K., Safe, S. Identification of a functional imperfect estrogen-responsive element in the 5?-promoter region of the human cathepsin D gene. Biochemistry 36, 7793-7801 (1997).
53. Ikeda, K., Orimo, A., Higashi, Y., Muramatsu, M., Inoue, S. Efp as a primary estrogen-responsive gene in human breast cancer. FEBS Lett 472, 9-13 (2000).
54. Watanabe, T. et al. Isolation of estrogen-responsive genes with a CpG island library. Mol Cell Biol 18, 442-449 (1998).
55. Ikeda, K. et al. Promoter analysis and chromosomal mapping of human EBAG9 gene. Biochem Biophys Res Commun 273, 654-660 (2000).
56. Norris, J. et al. Identification of a new subclass of Alu DNA repeats which can function as estrogen receptor-dependent transcriptional enhancers. J. Biol. Chem 270, 22777-22782 (1995).